Seven publications (n = 132) reporting data of COVID-19 patients showed a significant reduction in serum CRP levels after treatment (MD = −45.02 [95%-CI: −82.64; −7.39] mg/dL, I2 = 95%, p = 0.026) (Figure 3A). The gene discussed is CRP; the disease is COVID-19.